AboTA
News
24.05.2016
Almirall and Bicosome enter into a collaboration and sublicense agreement for the development of topical drug delivery formulations
Almirall S.A., the global pharmaceutical company based in Barcelona, and Bicosome, a start-up company that develops and commercializes high performance cosmetic and dermopharmaceutical ingredients, announced that they have entered into a research, collaboration and sublicense agreement for the development of multiple topical dermatological products, based upon Bicosome’s proprietary patented delivery technology platform, Bicosome® Technology. In […]
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one of the world’s fastest-growing medical aesthetic regions, the Asia Pacific market is an important one for SculpSure and our entire product portfolio. Our Asia-Pac subsidiaries […]
09.10.2015
SOLTA MEDICAL RAIDS DISTRIBUTOR OF COUNTERFEIT THERMAGE® MACHINES
Solta Medical, Inc. (“Solta“), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., announced today a brand enforcement action taken against a distributor of counterfeit Thermage® machines. Solta is the registered proprietor of the well-known Thermage® trademark in Singapore. The Thermage® CPT System is a medical device which is registered with the Singapore Health […]